News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
101,975 Results
Type
Article (5782)
Company Profile (61)
Press Release (96130)
Multimedia
Podcasts (13)
Webinars (2)
Section
Business (32964)
Career Advice (221)
Deals (5343)
Drug Delivery (13)
Drug Development (16736)
Employer Resources (19)
FDA (1620)
Job Trends (2301)
News (54223)
Policy (2986)
Tag
2027 Pharm Country Standard (1)
Academia (284)
Accelerated approval (5)
Adcomms (2)
Allergies (9)
Alliances (7450)
ALS (16)
Alzheimer's disease (126)
Antibody-drug conjugate (ADC) (227)
Approvals (1709)
Artificial intelligence (86)
Autoimmune disease (38)
Automation (5)
Bankruptcy (29)
Best Places to Work (1868)
BIOSECURE Act (2)
Biosimilars (39)
Biotechnology (40)
Bladder cancer (36)
Brain cancer (27)
Breast cancer (236)
Cancer (2167)
Cardiovascular disease (19)
Career advice (187)
Career pathing (2)
CAR-T (126)
CDC (2)
Cell therapy (286)
Cervical cancer (7)
Clinical research (14364)
Collaboration (455)
Company closure (2)
Compensation (185)
Complete response letters (3)
COVID-19 (332)
CRISPR (24)
C-suite (212)
Cystic fibrosis (9)
Data (1644)
Denatured (6)
Depression (19)
Diabetes (35)
Diagnostics (1001)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (60)
Drug pricing (15)
Drug shortages (1)
Duchenne muscular dystrophy (45)
Earnings (15431)
Editorial (7)
Employer branding (4)
Employer resources (16)
Events (17200)
Executive appointments (244)
FDA (2270)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (5)
Frontotemporal dementia (1)
Funding (341)
Gene editing (57)
Generative AI (3)
Gene therapy (88)
GLP-1 (129)
Government (364)
Guidances (125)
Healthcare (2832)
HIV (4)
Huntington's disease (5)
IgA nephropathy (13)
Immunology and inflammation (66)
Immuno-oncology (31)
Indications (31)
Infectious disease (355)
Inflammatory bowel disease (23)
Inflation Reduction Act (6)
Influenza (13)
Intellectual property (57)
Interviews (37)
IPO (2738)
IRA (7)
Job creations (472)
Job search strategy (150)
JPM (16)
Kidney cancer (9)
Labor market (11)
Layoffs (109)
Leadership (5)
Legal (407)
Liver cancer (25)
Longevity (1)
Lung cancer (314)
Lymphoma (131)
Machine learning (8)
Management (6)
Manufacturing (151)
MASH (21)
Medical device (1023)
Medtech (1025)
Mergers & acquisitions (2827)
Metabolic disorders (128)
Multiple sclerosis (26)
Neurodegenerative disease (38)
Neuropsychiatric disorders (13)
Neuroscience (285)
NextGen: Class of 2026 (805)
Non-profit (273)
Now hiring (13)
Obesity (67)
Opinion (37)
Ovarian cancer (113)
Pain (31)
Pancreatic cancer (122)
Parkinson's disease (25)
Partnered (8)
Patents (121)
Patient recruitment (109)
Peanut (2)
People (10184)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase 1 (7024)
Phase 2 (6421)
Phase 3 (3383)
Pipeline (1384)
Policy (22)
Postmarket research (110)
Preclinical (2297)
Press Release (28)
Prostate cancer (66)
Psychedelics (9)
Radiopharmaceuticals (117)
Rare diseases (101)
Real estate (796)
Recruiting (10)
Regulatory (2950)
Reports (12)
Research institute (373)
Resumes & cover letters (39)
Rett syndrome (1)
RNA editing (6)
RSV (3)
Schizophrenia (20)
Series A (77)
Series B (47)
Service/supplier (2)
Sickle cell disease (10)
Special edition (3)
Spinal muscular atrophy (4)
Sponsored (4)
Startups (794)
Stomach cancer (6)
Supply chain (9)
Tariffs (8)
The Weekly (7)
Vaccines (126)
Venture capital (26)
Weight loss (37)
Women's health (12)
Worklife (1)
Date
Last 7 days (120)
Last 30 days (418)
Last 365 days (6646)
2026 (584)
2025 (6724)
2024 (7677)
2023 (8724)
2022 (10427)
2021 (10425)
2020 (8614)
2019 (5946)
2018 (4545)
2017 (4860)
2016 (4043)
2015 (4694)
2014 (3140)
2013 (2386)
2012 (2817)
2011 (2834)
2010 (2441)
Location
Africa (79)
Alabama (8)
Arizona (29)
Asia (7643)
Australia (1082)
California (3064)
Canada (592)
China (441)
Colorado (117)
Connecticut (85)
Delaware (94)
Europe (14078)
Florida (233)
Georgia (23)
Hawaii (2)
Idaho (6)
Illinois (125)
India (14)
Indiana (104)
Iowa (9)
Japan (104)
Kansas (19)
Kentucky (11)
Louisiana (4)
Maine (5)
Maryland (241)
Massachusetts (1777)
Michigan (37)
Minnesota (102)
Mississippi (2)
Missouri (17)
Montana (3)
Nebraska (4)
Nevada (8)
New Hampshire (8)
New Jersey (627)
New York (505)
North Carolina (251)
Northern California (1488)
Ohio (58)
Oklahoma (4)
Oregon (9)
Pennsylvania (405)
Puerto Rico (1)
Rhode Island (4)
South America (111)
South Carolina (9)
Southern California (1310)
Tennessee (13)
Texas (434)
United States (8458)
Utah (32)
Virginia (31)
Washington D.C. (5)
Washington State (205)
West Virginia (1)
Wisconsin (28)
101,975 Results for "solid biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Solid Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 5, 2026
January 6, 2026
·
1 min read
Press Releases
Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia
January 13, 2026
·
7 min read
Press Releases
Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101
January 14, 2026
·
10 min read
Press Releases
Solid Biosciences to Participate at Upcoming Investor Conferences - November 11, 2025
November 12, 2025
·
1 min read
Press Releases
Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101
November 18, 2025
·
8 min read
Press Releases
Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies
January 6, 2026
·
2 min read
Press Releases
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 1, 2025
December 2, 2025
·
1 min read
Press Releases
Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors
January 12, 2026
·
1 min read
Press Releases
Solid Biosciences Announces Duchenne Muscular Dystrophy Added to National Recommended Uniform Screening Panel by the U.S. Department of Health and Human Services
December 17, 2025
·
6 min read
1 of 10,198
Next
